XCE Tirzepatide 99% Pure White Powder for Research Use - High Quality GLP-1/GIP Dual Agonist

XCE tirzepatide is a high purity white powder compound developed for research applications. This dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist demonstrates superior efficacy in glucose control and weight management compared to single receptor agonists.

The XCE tirzepatide formulation shows significantly enhanced performance in metabolic regulation studies, with particular effectiveness in type 2 diabetes research models. Its unique dual agonist mechanism provides superior glycemic control and weight reduction effects.

Our XCE tirzepatide is manufactured under strict quality control standards, ensuring consistent 99% purity as verified by HPLC analysis. The product is supplied as a lyophilized powder with excellent stability when stored properly.

Research indicates that XCE tirzepatide's greater affinity for GIP receptors combined with GLP-1 receptor activity produces more substantial reductions in hyperglycemia compared to selective GLP-1 receptor agonists alone. This makes it an important compound for metabolic disorder research.

Note: This product is intended for research purposes only and not for human consumption. Proper handling procedures should always be followed when working with research compounds.